Allergic Conjunctivitis Treatment Market is anticipated to grow at a significant CAGR during the forecast period. Allergic conjunctivitis refers to a common ophthalmic disorder where the conjunctiva of the eye develops an inflammation due to an allergic reaction, a resultant of an individual’s interaction with an allergen. The market growth is majorly attributable to the rising prevalence of allergic conjunctivitis among the global population. Recently, the prevalence of eye-related allergies has considerably increased due to a number of factors such as rapid urbanization and an increasing number of allergens. This disease is affecting a significant proportion of the global population but may often get ignored and underdiagnosed, both by the patient as well as the healthcare specialists.
Although the increasing awareness among the global population is projected to surge the demand for treatment for ocular conditions during the forecast period. Adding to this, a number of biopharmaceutical companies are planning to invest in R&D initiatives for the development of novel drugs and therapies for the treatment of this disorder. For instance, in July 2020, Zhaoke Ophthalmology Pharmaceutical Ltd. and IACTA Pharmaceuticals signed an agreement to accelerate the development of drugs called IC 265 and IC 270. The former is developed to treat dry eye and the latter for ocular allergy. Adding to this, a strong influx of generic versions of prominent drugs is likely to create growth opportunities for the global market during the forecast period. Furthermore, the increasing instances of prescription (Rx) drugs to over-the-counter (OTC) switches are also expected to boost market growth.
Some key players operating in the market include Novartis AG, Bausch Health Companies, Inc., Allergan, Akorn Inc., and others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
To Request a Sample of our Report on Allergic Conjunctivitis Treatment Market: https://www.omrglobal.com/request-sample/allergic-conjunctivitis-treatment-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered
- Regions Covered- Globally
- Competitive Landscape: Novartis AG, Bausch Health Companies, Inc., Allergan, Akorn Inc.
A full Report of Allergic Conjunctivitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/allergic-conjunctivitis-treatment-market
Allergic Conjunctivitis Treatment Market – Segmentation
By Type
- Acute Allergic Conjunctivitis Treatment
- Chronic Allergic Conjunctivitis Treatment
Allergic Conjunctivitis Treatment Market Segmentation by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
